The targets of these cases range from compounding pharmacies to medspas, and in taking on a quickly-growing pool of defendants, Novo Nordisk leans heavily on safety concerns: It consistently alleges in its complaints and other filings that compounded semaglutide products may use unapproved salt forms, come from dubious bulk suppliers, or lack the quality controls that the FDA-approved products undergo
These are signs of your progress
However, and this is where the nuance really comes into play, the underlying condition for which you are taking Tirzepatide often dictates eligibility
For some reason, it is more prevalent in the lungs upper lobes
Over time, maintaining those lines open between patient and provider helps to identify issues before they become serious
Your provider can guide you if your routine changes